{
    "clinical_study": {
        "@rank": "85831", 
        "arm_group": [
            {
                "arm_group_label": "remifentanil", 
                "arm_group_type": "Active Comparator", 
                "description": "remifentanil, short acting opioid"
            }, 
            {
                "arm_group_label": "ketamine", 
                "arm_group_type": "Active Comparator", 
                "description": "ketamine, intravenous anesthetic"
            }
        ], 
        "brief_summary": {
            "textblock": "In this prospective, randomized, clinical trial, we have investigated the effects of\n      ketamine-based and remifentanil-based anesthetic protocol on perioperative serum cystatin-c\n      levels, and creatinine and/or cystatin-c based eGFR equations in terms of acute kidney\n      injury in CABG surgery.This study was approved by the Ethics Committee of Hospital and all\n      patients were informed and gave written consent. Patients scheduled for elective CABG with\n      cardiopulmonary bypass. Patients were randomly allocated to anesthesia with\n      remifentanil-propofol-midazolam (RPM) group or ketamine-propofol-midazolam (KPM) group.\n      Blood samples were obtained before induction of anesthesia (baseline), at the end of the\n      operation, and postoperative days 1, 2, and 4."
        }, 
        "brief_title": "A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        patients undergoing  elective CABG with cardiopulmonary bypass\n\n        Exclusion Criteria:\n\n        patients undergoing emergency operation, combined operation, off-pump surgery, repeat\n        surgery or valve surgery, patients presenting with chronic kidney disease or renal\n        impairment, patients younger than 18 years old and neurological and/or psychiatric\n        disturbances."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "37", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02113150", 
            "org_study_id": "TurkiyeYIH", 
            "secondary_id": "Zaslidem"
        }, 
        "intervention": [
            {
                "arm_group_label": "ketamine", 
                "description": "renal function", 
                "intervention_name": "remifentanil", 
                "intervention_type": "Drug", 
                "other_name": "Ultiva"
            }, 
            {
                "arm_group_label": "remifentanil", 
                "description": "renal function", 
                "intervention_name": "Ketamine", 
                "intervention_type": "Drug", 
                "other_name": "ketalar"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ketamine", 
                "Remifentanil", 
                "Cystatins"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "troponin t,cystatin-c,ketamine,remifentanil", 
        "lastchanged_date": "April 9, 2014", 
        "link": {
            "description": "TYIH ETHICS COMMITTEE", 
            "url": "http://www.tyih.gov.tr"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey", 
                        "zip": "06550"
                    }, 
                    "name": "Turkey Yuksek Ihtisas Education and Research Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey", 
                        "zip": "06100"
                    }, 
                    "name": "Asl\u0131 Demir"
                }
            }
        ], 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery", 
        "other_outcome": {
            "measure": "GFR value", 
            "safety_issue": "Yes", 
            "time_frame": "2 months"
        }, 
        "overall_official": {
            "affiliation": "Turkey Yuksek Ihtisas Education and Research Hospital", 
            "last_name": "Asl\u0131 Demir", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "creatinin, BUN", 
            "safety_issue": "Yes", 
            "time_frame": "2 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02113150"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Turkiye Yuksek Ihtisas Education and Research Hospital", 
            "investigator_full_name": "asl\u0131 demir", 
            "investigator_title": "Z.Asl\u0131 Demir, MD, Assoc.Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Cystatin-c level", 
            "safety_issue": "Yes", 
            "time_frame": "2 months"
        }, 
        "source": "Turkiye Yuksek Ihtisas Education and Research Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Turkiye Yuksek Ihtisas Education and Research Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}